ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626433 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626433; 2) Community: the network communities that were significantly associated with the response to NSC 626433; 3) Molecule: the relationships between components within communities and NSC 626433; 4) MDR: the compounds that were significantly associated with the NSC 626433.

NSC Compound Enrichment Correlation
NSC 701373 3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 4-(4-methoxy-1-naphthalenyl)-2-oxo- 0.00648124190744027 0.37883557
NSC 755523 Null 0.00648124190744027 0.42682478
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.00648124190744027 0.37419838
NSC 28002 Naphtho[2,1-b]quinolizinium, 7-methyl-, chloride 0.0064812419074403 0.049771193
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.0064812419074403 0.49325579
NSC 621321 Null 0.0064812419074403 0.47696021
NSC 637603 2H-1,4-Benzothiazin-3-one, 3,4-dihydro-2-[2-[(2,5-dimethylphenyl)amino]-2-oxoethyl]- 0.00705866970012649 -0.44077563
NSC 677395 2-Azido-10-[(4-dimethylamino)butyl]phenothiazine, oxalate salt 0.00705866970012649 0.45564413
NSC 681750 Null 0.00705866970012649 -0.38357266
NSC 715740 Null 0.00705866970012649 -0.38750906
Total:76  Current:14    [First] [Prev] [Next] [Last]